Business
Pharmaceutical Giants Consider Merger
AstraZeneca and Bristol-Myers Squibb are reportedly in talks for a potential merger, causing significant stock market fluctuations. Analysts question the strategic rationale behind such a move.
Coverage timeline — 1 article
MarketWatch
AstraZeneca shares were slumping while Bristol-Myers Squibb was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place.
2026-08-03 10:43 UTC